Structure Therapeutics Inc.
GPCR$835M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSOUTH SAN FRANCISCO218 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Aug 5, 2026
6wMarket Overview
Stock performance and key metrics
GPCR News
Catalyst Timeline
3 upcoming, 1 past
Drug Pipeline
GSBR-1290
Overweight or Obesity
Aleniglipron
Obesity, Overweight, or Chronic Weight Management
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
GSBR-1290 | Phase 2 | Overweight or Obesity | - | - |
Aleniglipron | Phase 2 | Obesity, Overweight, or Chronic Weight Management | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply